Urinary 8-oxoguanine as a predictor of survival in patients undergoing radiotherapy

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 4, 2012, Pages 629-634

  Roszkowski, Krzysztof ^a,b   Olinski, Ryszard ^b  

^a Regional Oncology Centre Bydgoszcz   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; CELL DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; ELECTROCHEMICAL DETECTION; FEMALE; HEAD AND NECK CANCER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; SURVIVAL PREDICTION; URINARY EXCRETION;

ADULT; AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; GUANINE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROGNOSIS; RADIATION ONCOLOGY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84859418108     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0981     Document Type: Article

References (16)

1. Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer 2005;5:867-75. (Pubitemid 41746031)
2. Allan JM, Travis LB. Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 2005;5:943-55. (Pubitemid 41781694)
3. Roszkowski K, Jozwicki W, Blaszczyk P, Mucha-Malecka A, Siomek A. Oxidative damage DNA: 8-oxoGua and 8-oxodG as the molecular markers of the cancer disease. Med Sci Monit 2011;17:329-33.
4. Haghdoost S, Svoboda P, Naslund I, Harms-Ringdahl M, Tilikides A, Skog S. Can 8-oxo-dG be used as a predictor for individual radiosensitivity? Int J Radiat Oncol Biol Phys 2001;50:405-10. (Pubitemid 32472269)
5. Cooke MS, Olinski R, Loft S. Measurement and meaning of oxidatively modified DNA lesions in urine. Cancer Epidemiol Biomarkers Prev 2008;17:3-14. (Pubitemid 351196268)
6. Ravanat JL, Guicherd P, Tuce Z, Cadet J. Simultaneous determination of five oxidative DNA lesions in human urine. Chem Res Toxicol 1999;12:802-8. (Pubitemid 29451165)
7. Foksinski M, Rozalski R, Guz J, Ruszkowska B, Sztukowska P, Piwowarski M, et al. Urinary excretion of DNA repair products correlates with metabolic rates as well as with maximum life spans of different mammalian species. Free Radic Biol Med 2004;37:1449-54. (Pubitemid 39349245)
8. Poulsen HE, Loft S, Prieme H, Vistisen K, Lykkesfeldt J, Nyyssonen K, et al. Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Rad Res 1998;29:565-71. (Pubitemid 29112725)
9. Siomek A, Gackowski D, Rozalski R, Dziaman T, Szpila A, Guz J, et al. Higher leukocyte 8-oxo-7,8-dihydro-2′-deoxyguanosine and lower plasma ascorbate in aging humans? Antioxid Redox Signal 2007;9:143-50. (Pubitemid 44901880)
10. Foksinski M, Bialkowski K, Skiba M, Ponikowska I, Szmurlo W, Olinski R. Evaluation of 8-oxodeoxyguanosine, typical oxidative DNA damage, in lymphocytes of ozone-treated arteriosclerotic patients. Mutat Res 1999;438:23-7. (Pubitemid 29015747)
11. STATISTICA. [cited 2009]. Available from: http://www.statsoft.com/ products/.
12. Weijl NI, Elsendoorn TJ, Lentjes EG, Hopman GD, Wipkink-Bakker A, Zwinderman AH, et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer 2004;40:1713-23. (Pubitemid 38902907)
13. Roszkowski K, Gackowski D, Rozalski R, Dziaman T, Siomek A, Guz J, et al. Small field radiotherapy of head and neck cancer patients is responsible for oxidatively damaged DNA/oxidative stress on the level of a whole organism. Int J Cancer 2008;123:1964-7.
14. Dziaman T, Huzarski T, Gackowski D, Rozalski R, Siomek A, Szpila A, et al. Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Cancer Epidemiol Biomarkers Prev 2009;18:2923-8.
15. Kyrtopoulos SA. Variability in DNA repair and individual susceptibility to genotoxins. Clin Chem 1995;41:1848-53.
16. Strauss B, Hanawalt P, Swenberg J. Risk assessment in environmental carcinogenesis. An American Association for Cancer Research special conference in cancer research cosponsored by the Environmental Mutagen Society. Cancer Res 1994;54:5493-6.